Bolt Biotherapeutics, Inc.
BOLT
$5.44
$0.29385.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -52.82% | -57.48% | -53.69% | -55.06% | -41.45% |
| Total Receivables | -50.00% | -21.11% | 34.58% | -84.82% | -50.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -1.87% | -22.39% | -32.71% | -27.53% | -37.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 371.35% | -- | -- |
| Total Current Assets | -49.97% | -55.28% | -51.93% | -54.45% | -41.35% |
|
|
|||||
| Total Current Assets | -49.97% | -55.28% | -51.93% | -54.45% | -41.35% |
| Net Property, Plant & Equipment | 2.76% | 1.58% | 3.40% | -19.18% | -17.51% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -41.97% | -70.76% | -70.91% | -59.19% | -19.56% |
| Total Assets | -39.20% | -39.91% | -37.65% | -37.65% | -34.88% |
|
|
|||||
| Total Accounts Payable | -29.50% | -30.87% | -49.55% | -59.75% | -23.54% |
| Total Accrued Expenses | -27.28% | -35.64% | -33.17% | -0.21% | -25.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.56% | -16.87% | -19.09% | 5.37% | 16.04% |
| Total Finance Division Other Current Liabilities | -48.19% | 77.19% | 70.56% | 72.76% | 192.23% |
| Total Other Current Liabilities | -48.19% | 77.19% | 70.56% | 72.76% | 192.23% |
| Total Current Liabilities | -31.23% | -18.90% | -22.49% | -3.56% | 1.60% |
|
|
|||||
| Total Current Liabilities | -31.23% | -18.90% | -22.49% | -3.56% | 1.60% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 36.03% | 33.75% | 31.66% | -15.54% | -15.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -39.76% | -40.32% | -60.44% | -61.97% | -62.51% |
| Total Liabilities | -4.33% | 0.82% | -9.80% | -20.79% | -21.10% |
|
|
|||||
| Common Stock & APIC | 0.76% | 1.24% | 1.58% | 1.79% | 2.05% |
| Retained Earnings | -12.80% | -16.89% | -17.33% | -18.79% | -20.04% |
| Treasury Stock & Other | 86.36% | 211.11% | 162.16% | 217.82% | 80.79% |
| Total Common Equity | -54.76% | -55.06% | -49.27% | -43.84% | -39.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -54.76% | -55.06% | -49.27% | -43.84% | -39.59% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -54.76% | -55.06% | -49.27% | -43.84% | -39.59% |
|
|
|||||